Sort
51,593 grants matching “hepatitis”
Sample Processing and Analytical Methods Development for New Anticancer Agents
$678,469William Douglas Figg · Division Of Clinical Sciences - Nci · ZIC · FY2013 · CA
NATURAL HISTORY OF HCV INFECTION IN DRUG USERS
$678,427Montefiore Medical Center (Bronx, Ny) · R01 · FY2003 · DA
Brief Intervention for Drug Misuse for the Emergency Department (BIDMED)
$678,372Roland C Merchant · Rhode Island Hospital · R01 · FY2011 · DA
Investigating the role of frailty on outcomes in acutely ill patients with cirrhosis undergoing liver transplantation in the acute care setting
$678,273Jennifer C. Lai · University Of California, San Francisco · R01 · FY2024 · DK
The function and regulation of the novel pregnancy-specific hexokinase HKDC1
$678,252Brian Thomas Layden · University Of Illinois At Chicago · R01 · FY2020 · DK
PATHOGENESIS OF HEPATITIS B VIRUS IN TRANSGENIC MICE
$678,245Scripps Research Institute · R01 · FY2000 · CA
Rhesus HHV-8 homologue in AIDS-related malignancies
$678,245Scott W Wong · Oregon Health & Science University · R01 · FY2019 · CA
Treating secondary cardiomyopathies by mimicking the adaptive hepatic glucose fasting response
$678,171Brian Jesse Debosch · Washington University · R01 · FY2021 · HL
Mechanistic Studies of Combination Adjuvants to Target B Cells in Vaccines
$678,060Luc Teyton · Scripps Research Institute, The · U01 · FY2023 · AI
Mechanistic Studies of Combination Adjuvants to Target B Cells in Vaccines
$678,060Luc Teyton · Scripps Research Institute, The · U01 · FY2022 · AI
Roles of Neogenin and Matriptase-2 in Iron Homeostasis
$678,029An-Sheng Zhang · Oregon Health & Science University · R01 · FY2025 · DK
Roles of Neogenin and Matriptase-2 in Iron Homeostasis
$678,029An-Sheng Zhang · Oregon Health & Science University · R01 · FY2024 · DK
Biomarkers for Peripheral Circadian Clocks in Humans
$678,006Kenneth P Wright · University Of Colorado · R01 · FY2024 · HL
Metabolic impact of FGF-21 in adipose tissue and liver of PLWH
$677,982Jordan E Lake · University Of Texas Hlth Sci Ctr Houston · R01 · FY2020 · DK
Autoimmune Basis of Acquired Lipodystrophies
$677,951Abhimanyu Garg · Ut Southwestern Medical Center · R01 · FY2025 · DK
Discovery of novel therapeutic targets for NASH through deep phenotyping of human knockouts and mechanistic studies
$677,927Danish Saleheen · Columbia University Health Sciences · R01 · FY2022 · DK
Project 2: Durable impact of HCV on innate and adaptive immunity
$677,806Georg Michael Lauer · Massachusetts General Hospital · U19 · FY2025 · AI
Extended-Release Naltrexone Opioid Treatment at Jail-to-Community Re-entry
$677,777Joshua D Lee · New York University School Of Medicine · U01 · FY2016 · DA
Increasing Involvement of MSM in the Continuum of Care in Kazakhstan
$677,724Elwin Wu · Columbia Univ New York Morningside · R01 · FY2019 · DA
Repurposing Leflunomide to Delay Progression of Smoldering Multiple Myeloma in African Americans
$677,645Steven Terry Rosen · Beckman Research Institute/City Of Hope · R01 · FY2025 · CA
Carboxylesterase 1 Genetic Variation and Methylphenidate in ADHD
$677,621John S Markowitz · University Of Florida · R01 · FY2018 · HD
Addiction, HIV and Tuberculosis in Malaysian Criminal Justice Settings
$677,593Frederick Lewis Altice · Yale University · R01 · FY2016 · DA
Living Cell Arrays for Real Time Functional Genomics
$677,573Martin L Yarmush · Massachusetts General Hospital · R01 · FY2007 · AI
Understanding and Improving the Effectiveness of Public Health Laboratory Networks for Infectious Diseases in Ghana
$677,548Lee Frederick Schroeder · University Of Michigan At Ann Arbor · R01 · FY2021 · AI
A prospective, randomized, clinical trial to evaluate two novel therapies, mycoph
$677,495Timothy Ross Morgan · Southern California Inst For Res/Educ · U01 · FY2015 · AA